Stock Taper
SCLXW
SCILEX HOLDING COMPANY
NASDAQ
$0.11
▼ DOWN 34.15% (-0.05)

KEY STATISTICS

Market Cap$29.46 M
52w High$0.17
52w Low$0.11
Dividend Yield
Frequency
P/E
Volume262
Shares Out.8.49M

COMPANY

LEADERSHIP

Henry H. Ji
CHIEF EXECUTIVE
Henry H. Ji

COMPENSATION 2026

Salary$917,494
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$54,023
Total$7,373,977

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 5, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
34

UPCOMING EARNINGS

DateDec 2, 2026
DayWednesday
Rev. Est.$17.00M
DEC
2
WED

PRICE

$0.11 ▼ DOWN 34.15% (−$0.05)
$0.10$0.13$0.15$0.172:24 PM2:28 PM2:33 PM2:37 PM2:41 PM2:46 PM2:50 PM0.11

About Scilex Holding Company

https://www.scilexholding.com ↗

Scilex Holding Company, a Palo Alto-based biopharmaceutical firm and Sorrento subsidiary, develops non-opioid pain therapies, including ZTlido for neuropathic pain and various products in clinical trials for conditions like radiculopathy, back pai...

INDUSTRY

Drug Manufacturers - General

A PRODUCT SCILEX HOLDING COMPANY IS KNOWN FOR

GLOPERBA®
GLOPERBA®

GLOPERBA® is the FDA-approved liquid colchicine for gout flare prevention, launched in June 2024, offering flexible dosing for adults, especially those with renal or hepatic impairment.

COMPETITORS

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

10 PERCENT OWNER
SCLX Stock Acquisition JV LLC
Sale · 500.0K shares
2026-07-03
DIRECTOR, OFFICER: CFO, COO AND SECRETARY
Ma Stephen Hoi
Purchase · 650.0K shares
2026-04-17
DIRECTOR, OFFICER: EXEC CHAIR, CEO AND PRESIDENT
Ji Henry
Purchase · 3.3M shares
2026-04-16
DIRECTOR, OFFICER: EXEC CHAIR, CEO AND PRESIDENT
Ji Henry
Sale · 650.0K shares
2026-04-17

SECTORS PEERS

PEERPRICE
RVMD$209.46COMPARE
ADAG$4.02COMPARE
ACET$9.19COMPARE
GANX$2.00COMPARE
NRXP$3.56COMPARE
DXR$10.00COMPARE
LITS$0.99COMPARE
CRVO$2.62COMPARE